JPRN-UMIN000014064已完成2 期
A phase II study of the efficacy of Compression therapy by using surgical gloves for prevention of nab-paclitaxel-induced peripheral neuropathy in primary and metastatic breast cancer patients. - A phase II study of the efficacy of Compression therapy by using surgical gloves for prevention of nab-paclitaxel-induced peripheral neuropathy in breast cancer patients.
Kamigata Breast Cancer Study Group0 个研究点目标入组 40 人开始时间: 2014年5月27日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Multiple primary cancer. However, carcinoma in situ can be cured by local treatment is not included in multiple primary cancer. 2) Synchronous bilateral breast cancer. 3) Poorly controlled complication (infection, diabetes mellitus, and others). 4) Hypersensitivity to any agents necessary in the planned treatment. 5) Positive for HBs antigen. 6) Previous history of serious heart or lung disease 7) Peripheral sensory/motor neuropathy 8) Transfusion within 2 years 9) Previous history or receiving treatment of dementia or serious psychiatric disorder. 10) Large pleural effusion or ascites 11) Women who are pregnant, lactating or with childbearing potential. 12) Ineligible based on decision of an investigator.
研究者
相似试验
进行中（未招募）
不适用
Ofatumumab for the therapy of malignant lymphoproliferative disorder, called Waldenström’s macroglobulinemia (WM).Relapsed or refractory Waldenström’s Macroglobulinemia.EUCTR2012-004998-53-GRational and Kapodistrian University of Athens
尚未招募
2 期
Phase II study to evaluate the preventive effect and safety of lubiprostone in opioid-induced constipatiocancer painJPRN-jRCTs051230150Kuriyama Toshiyuki37
进行中（未招募）
1 期
Study the effects of azacitidine and lenalidomide combination therapy in patients with acute myeloid leukemiaMedDRA version: 21.0Level: LLTClassification code 10024289Term: Leukaemia acuteSystem Organ Class: 100000004864ACUTE MYELOID LEUKEMIAEUCTR2015-001767-40-ITAZIENDA OSPEDALIERA OSPEDALI RIUNITI MARCHE NORD66
已完成
2 期
A phase II study to evaluate the effect on the combination chemotherapy of CPT-11 and S-1 for advanced/recurrent colon cancer which combines genetic analysis on adverse events (OGSG 0405)Patients with advanced and/or recurrent colon cancerJPRN-UMIN000000855OGSG30
招募中
2 期
A phase II study to evaluate the effectiveness of S-1 + Cetuximab for patients with advanced/recurrent colon cancer who cannot undergo intensive therapyadvanced/recurrent colon cancer patients with RAS wild-type tumors who cannot undergo intensive therapyJPRN-UMIN000018484HO HOKKAIDO CANCER CENTER Division of Gastroenterology57